(lp0
S'5.20 MarketWatch - Nov 1, 2009 icad Inc. iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer.'
p1
aS'Market Center: Watching the Levels for iCAD, Inc.  BVN - 9 hours ago Looking at shares of iCAD, Inc. , the company presently has a Gross Margin  ratio of 0.50987. This number is calculated from the research by University of Rochester professor Robert Novy-Marx.'
p2
aS'iCAD Inc Risk Points versus Health Care CML News - Apr 8, 2017 This is a scatter plot analysis of the critical risk points from the option market for iCAD Inc  compared to its own past and the Health Care ETF.'
p3
aS"Accelerated Earnings Growth, But What's Ahead for iCAD, Inc.  The Herald - 17 hours ago Shares of iCAD, Inc.  have been experiencing an accelerated earnings and sales growth over the past 5 years."
p4
aS'iCAD To Showcase PowerLook Tomo Detection Technology At SBI/ACR Breast Imaging ... PR Newswire  - Apr 6, 2017 NASHUA, N.H. and LOS ANGELES, April 6, 2017 /PRNewswire/ --  - iCAD , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer,&nbsp;...'
p5
aS'First-Ever Analysis of Intraoperative Radiation Therapy with Xoft System as a ... PR Newswire  - Dec 6, 2016 NASHUA, N.H. and SAN ANTONIO, Dec. 6, 2016 /PRNewswire/ -- Booth #257 -- iCAD, Inc. , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer,&nbsp;...'
p6
aS'iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement ... GlobeNewswire  - May 27, 2015 NASHUA, N.H., May 27, 2015  -- iCAD, Inc.  announced today that it is withdrawing its full year 2015 financial guidance due to general uncertainty related to reimbursement for non-melanoma skin cancer in the United&nbsp;...'
p7
aS'iCAD Receives FDA Approval For PowerLook Tomo Detection PR Newswire  - Mar 27, 2017 NASHUA, N.H., March 27, 2017 /PRNewswire/ -- iCAD , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that PowerLook&nbsp;...Unusual Volume Buzz: iCAD, Inc. , Cancer Genetics, Inc. (NASDAQ ... - Benchmark Monitor'
p8
aS"Most Volatile Stock of Thursday: iCAD, Inc.'s  stock price concludes at ... WsNews 4investors - 21 hours ago iCAD, Inc.  stock price distance from twenty day simple moving average surged at 9.05% while its distance from fifty day simple moving average raised 23.43% along with 18.77% above distance from two hundred simple moving averages."
p9
aS"Option Market Alert: iCAD Inc Implied Price Swing Hits An Unsually High Level CML News - Apr 13, 2017 Risk Alert: Before we dive into any analysis we simply note that iCAD Inc  risk is elevated. We'll detail it below -- but that's the lede -- the option market is starting to flash those neon lights that signal &quot;risk is rising&quot; with an IV30 ..."
p10
a.